Interface between authorship, industry and science in the domain of therapeutics

Item Type

Language

English

Abstract

Background Changes in the character of medical authorship. Aims To compare the impact of industry-linked and non-industry linked articles. Method We compared articles on sertraline being coordinated by a medical writing agency with articles not coordinated in this way. We calculated numbers of Medline-listed articles per author, journal impactfactors, literature profiles and citation rates of both sets of articles. Results Non-agency-linked articles on sertraline had an average of 2.95 authors per article, a mean length of 3.4 pages, a mean Medline listing of 37 articles per author (95% CI 27–47) and a mean literature profile of 283 per article (95% CI 130–435). Agency-linked articles on sertraline had an average of 6.6 authors per article, a mean length of 10.7 pages, a mean Medline listing of 70 articles per author (95% CI 62–79) and a mean literature profile of 1839 per article (95% CI 1076-2602). The citation rate for agency articles was 20.2 (95% CI 13.4–27.0) and for non-agency articles it was 3.7 (95% CI 3.3–8.1). Conclusions The literature profiles and citation rates of industry-linked and non-industry-linked articles differ. The emerging style of authorship in industry-linked articles can deliver good-quality articles, but it raises concerns for the scientific base of therapeutics.

Publication Year

2003

Publication Date

2003-07

Source

Cambridge Core

License

ISSN

0007-1250
1472-1465

Physical Description

vol. 183, n. 1, pp. 22-27

Citer cette ressource

Interface between authorship, industry and science in the domain of therapeutics, dans Science & Ignorance, consulté le 21 Novembre 2024, https://ignorancestudies.inist.fr/s/science-ignorance/item/4920

Export